WE RESPECT YOUR PRIVACY

Farmacia on line Dr. Canfora  has always distinguished itself for the respect of the regulations in force, that's why we have updated the privacy policy according to the new EU REGULATION 2016/679 GDPR. In the informative relative to the privacy policy are given all the indications on the type of sensitive data collected, on the aims of their treatment and the information related to your rights in this regard.
To make your browsing more enjoyable, farmaciacanfora.com and third-party tools used by this make use of cookies necessary for its operation and useful for the purposes described in the cookie policy available here. Click the button below or any other point on the page to continue.

  I ACCEPT COOKIES AND CONTINUING NAVIGATION   Find out more

Online pharmacy Dr. CanforaOnline pharmacy Dr. Canfora
Online pharmacy Dr. CanforaOnline pharmacy Dr. Canfora
Switch language
Choose a Gift
LOGIN
Category menu

DISCOUNT COUPON Click on the top to find out how to save even more with us. WELCOME TICKET and OVER200 active !!


On whole website  |   on OTC drugs

Dicloreum PATCHES painkillers

Diclofenac patches

Dicloreum PATCHES painkillers
-10%
Read reviews on  of  Read the reviews on
Mark: 4.9 / 5

Italian pharmacy certified by the Ministry of Health

Online:
€ 20,2520.25

Price in Store: € 22,50

Quantity:
- +

Dicloreum PATCHES painkillers

10 patches

Inflammatory based on diclofenac formulated in patches to be applied on areas affected by joint and musculoskeletal pain.


Indications

Local treatment of painful and inflammatory rheumatic or traumatic nature of the joints, muscles, tendons and ligaments.

Contraindications

Hypersensitivity 'to diclofenac, all ' acetylsalicylic acid or other anti-inflammatory preparations (NSAIDs) or any excipients of the finished product, as well as '' s isopropanol; Patients in whom you have experienced asthma, urticaria or acute rhinitis after taking acetylsalicylic acid or other inflammatory drugs (NSAIDs); damaged skin, regardless of the type of lesion: exudative dermatitis, eczema, infected lesion, burns or wounds; third trimester of pregnancy and lactation; patients with active peptic ulcer. Children and adolescents: l 'use in children and teenagers younger ' less than 16 years, and 'contraindicated.

Dosage

For cutaneous use only. The product should only be applied to intact healthy skin and should not be applied when you bathe or shower. The medicated plaster of diclofenac must be used for the more 'shortest time possible in relation to ' indication d 'use. Adults: the usual dosage regime and 'of 1 or 2 patches (or any other frequency evaluated in clinical trials for a specific product) daily (one application every 12 or 24 hours) for a period up to 14 days (or for any other number of days has been evaluated l 'use in clinical trials for a specific product). Children and adolescents under the age of 16: l 'use of this medicated plaster is not ' recommended in children and adolescents age 'less than 16 years because ' are not sufficient data available to evaluate the safety and 'effectiveness of the medicine.

Adolescents age 'equal to or greater than 16 years, if the product and ' need for a treatment period exceeding 7 days for the relief of pain, or if symptoms worsen, it is recommended to the patient or his family 's teenager to see a doctor. Elderly: this medicine should be used with caution in elderly patients as more susceptible to side effects. Method of administration: cut the envelope containing the medicated plaster as indicated. Extract a medicated plaster, remove the plastic film used to protect the adhesive surface and apply the patch on 'joint or the painful area. If necessary, the patch can 'to be held in place by an elastic band. Carefully reseal the envelope by pressing the edge where the drawstring closure. The patch should be used whole.

Warnings

If the medicated plasters of diclofenac are used on skin surfaces and extended for a prolonged period of time and not 'you can exclude the possibility ' of systemic adverse events. The medicated patch should only be applied to intact healthy skin and should not be applied to broken skin or open wounds. Patches should not come into contact with eyes or mucous membranes. The side effects can be minimized 's use of the most ' lowest effective dose for the most 'shortest duration of treatment necessary to control symptoms. Do not use with an occlusive dressing that does not pass air. Treatment should be discontinued immediately if you develop a rash after the 'application of the medicated plaster. Not administer simultaneously topically or systemically another medicine based on diclofenac or other NSAIDs.

Although systemic effects should be limited, the medicated plaster must be used with caution in patients with impaired renal, cardiac or hepatic function, history of peptic ulcer or inflammatory bowel disease or bleeding diathesis. Nonsteroidal anti-inflammatory drugs should be used with special care in elderly patients who are more prone to side effects. This medicine contains methyl parahydroxybenzoate and propyl parahydroxybenzoate. May cause allergic reactions (possibly delayed). It also contains propylene glycol, which can 'cause skin irritation. Patients should be advised to avoid exposure to direct sunlight or the light of solar lamps for about a day after the removal of the medicated plaster to reduce the risk of photosensitivity '.

Interactions

Since 'l ' systemic absorption of diclofenac following the 'use of medicated patches and ' very low, the risk of developing clinically significant interactions with other medicinal products and 'negligible.

Side Effects

Adverse reactions are listed by frequency, before the most 'frequent, using the following convention: common (> = 1/100, <1/10); uncommon (> = 1 / 1,000, <1/100); rare (> = 1 / 10,000 to <1 / 1,000); very rare (<1 / 10,000); unknown. Infections and infestations. Very rare: rash with pustules. Disorders of the immune system. Very rare: hypersensitivity '(including urticaria), angioneurotic edema, anaphylactoid reaction. Respiratory, thoracic and mediastinal disorders. Very rare: asthma. Skin and subcutaneous tissue. Common: rash, eczema, erythema, dermatitis (including allergic dermatitis and contact dermatitis), itching; rare: bullous dermatitis (eg bullous erythema), dry skin; Very rare: photosensitivity reactions '. General disorders and administration site conditions. Common: reactions at the administration site.

Pregnancy

The systemic concentration of diclofenac, compared with oral formulations, and 'more ' low following topical administration. Referring to 'experience of treatment with NSAIDs for systemic administration, the following is recommended: l ' inhibition of prostaglandin synthesis can 'have adverse effects on pregnancy and / or on the embryo / fetal development. Results of epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after 'use of an inhibitor of prostaglandin synthesis in the early stages of pregnancy. It 'was considered that the risk increases with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitor has been shown to result in increased pre- and post-implantation loss and mortality 'embryo-fetal. In addition, an increased incidence of various malformations, including cardiovascular, and 'been reported in animals which prostaglandin synthesis inhibitors were administered during organogenesis period.

During the first and second trimester of pregnancy, diclofenac should not be given unless clearly necessary. If diclofenac and 'used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept more ' minimized and the life of the most 'short treatment possible. During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to: toxicity 'cardiopulmonary (with premature closure of the ductus arteriosus and pulmonary hypertension); renal dysfunction, which can 'progress to renal failure with oligohydramnios; the mother and the neonate, at the end of pregnancy, to: possible prolongation of bleeding time, and antiplatelet effect which can 'occur even at very low doses; inhibition of uterine contractions resulting in delayed or prolonged labor. Consequently, diclofenac and 'contraindicated during the third trimester of pregnancy. Diclofenac passes into breast milk in small amounts '. However, at therapeutic doses of diclofenac medicated plasters there are no effects on the infant. Because of the lack of controlled studies in lactating women, the product should be used during the 'breastfeeding only on the advice of a health professional. In this circumstance, the medicated plasters of diclofenac should not be applied to the breast of breastfeeding mothers, it 'elsewhere on large areas of skin or for an extended period of time.

AIC code: 042685014

Dicloreum PATCHES painkillers Reviews

This is a counter medication, if you have a question Dr. Canfora respond in person.Ask for advice

LOGIN to write a review on this product.

Farmacia Canfora recommends:

Voltaren Emulgel GEL 2% 60 gr
-10%
In Store 12,26 €   Online 11,03
Online 11,03

Voltaren Emulgel GEL 2% 60 gr

View Item

Tachipirina 20CPR 500MG
-10%
In Store 4,90 €   Online 4,41
Online 4,41

Tachipirina 20CPR 500MG

View Item

Vo3dol Erbagil Emulgel (dolaren)
-17%
In Store 33,00 €   Online 27,40
Online 27,40

Vo3dol Erbagil Emulgel (dolaren)

View Item

Arnitop Painkiller
-14%
In Store 23,00 €   Online 19,80
Online 19,80

Arnitop Painkiller

View Item

Canesten Cream 1% 30g
-10%
In Store 11,66 €   Online 10,49
Online 10,49

Canesten Cream 1% 30g

View Item

HerbSardinia 10 TEN OIL BODY ESSENCE 100ml
-20%
In Store 27,90 €   Online 22,32
Online 22,32

HerbSardinia 10 TEN OIL BODY ESSENCE 100ml

View Item

Copyright © 2020   Powered by Ma2 Web.     eCom Platform